
"The continued lack of medical funding and healthcare infrastructure inform our view for the potential epidemic to be worse in India if it is not adequately contained," Fitch Solutions Country Risk and Industry Research (a unit of Fitch Group) said in its outlook for India's pharmaceutical market.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35Y773z
via
IFTTT
0 comments:
Post a Comment